[Biopharmaceutical evaluation of the intrarectal use of mefenamic acid. III. Effect of solubilizers on the biological availability of mefenamic acid from witepsol H15].
D000818:Animals; D001682:Biological Availability; D008528:Mefenamic Acid / Q000008:administration & dosage / Q000378:metabolism*; D011136:Polysorbates; D011817:Rabbits; D012995:Solubility; D013488:Suppositories; D014280:Triglycerides; D014508:Urea
D011136:Polysorbates; D013488:Suppositories; D014280:Triglycerides; C009683:witepsol; D008528:Mefenamic Acid; D014508:Urea
Biofarmaceutyczna ocena doodbytniczego stosowania kwasu mefenamowego. III. Wpływ solubilizatorów na dostepność biologiczna kwasu mefenamowego z witepsolu H15.